send to a friend by email

Dar Al-Shifa Pharmaceuticals Company achieves a net income of JD1.86 million in H1 2013

2013-08-18

According to company data for the first six months of the year, net profit after taxes reached 1,861,972 USD. PHARMACARE was listed on the PEX on April 23^rd, 2013, and income for the prior similar reporting period has not been disclosed. Total assets of the company reached 38,606,131 USD as of June 30^th, 2013, compared to total assets of 35,434,044 USD as of December 31^st, 2012, a net increase of 9.0%. Total liabilities of the company reached 15,536,285 USD as of June 30^th, 2013, compared to total liabilities of 14,006,310 USD as of December 31^st, 2012, a net increase of 10.9%. Net ownership equity of the company reached 23,069,846 USD (including 2,894,675 USD in Non-controlling interest) as of June 30^th, 2013, compared with a net ownership equity of 21,427,734 USD (including 2,222,137 USD in Non-controlling interest) as of December 31^st, 2012, a net increase of 7.7% in the last six months.